Literature DB >> 17931639

Selection of solubility parameters for characterization of pharmaceutical excipients.

Katarzyna Adamska1, Adam Voelkel, Károly Héberger.   

Abstract

The solubility parameter (delta(2)), corrected solubility parameter (delta(T)) and its components (delta(d), delta(p), delta(h)) were determined for series of pharmaceutical excipients by using inverse gas chromatography (IGC). Principal component analysis (PCA) was applied for the selection of the solubility parameters which assure the complete characterization of examined materials. Application of PCA suggests that complete description of examined materials is achieved with four solubility parameters, i.e. delta(2) and Hansen solubility parameters (delta(d), delta(p), delta(h)). Selection of the excipients through PCA of their solubility parameters data can be used for prediction of their behavior in a multi-component system, e.g. for selection of the best materials to form stable pharmaceutical liquid mixtures or stable coating formulation.

Mesh:

Substances:

Year:  2007        PMID: 17931639     DOI: 10.1016/j.chroma.2007.09.034

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  3 in total

1.  Quantification of surface amorphous content using dispersive surface energy: the concept of effective amorphous surface area.

Authors:  Jeffrey Brum; Daniel Burnett
Journal:  AAPS PharmSciTech       Date:  2011-07-02       Impact factor: 3.246

2.  The effects of supercritical carbon dioxide processing on progesterone dispersion systems: a multivariate study.

Authors:  James R Falconer; Jingyuan Wen; Sara Zargar-Shoshtari; John J Chen; Farid Mohammed; Judy Chan; Raid G Alany
Journal:  AAPS PharmSciTech       Date:  2012-09-20       Impact factor: 3.246

3.  Design of olanzapine/lutrol solid dispersions of improved stability and performances.

Authors:  Cristina Cavallari; Adamo Fini; Giancarlo Ceschel
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.